Sign in
CompletedNo phase

esTOCma, an App Used by Teachers: an RCT

Key facts

Who runs it
University of Valencia
Where
Spain1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
175 people enrolled
Started
26 Feb 2024
Ended
30 Jun 2024
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Use of esTOCma
Record updated
30 December 2025

Who can take part

Age
18 years to 99 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Being a practising teacher in non-university education
  • Working in the education field as a guidance counsellor, language teacher or therapeutic pedagogue

Who cannot take part

  • Having less than 18 years old
  • Working in a field other than those mentioned above

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of the present study is to assess the efficacy of a mobile application called esTOCma in promoting mental health literacy, reducing stigmatizing attitudes related to the Obsessive-Compulsive Disorder (OCD) and improving teachers' confidence in dealing with students that might have OCD. A parallel, randomized controlled trial with two conditions (experimental and control group) will be carried out in a sample of teachers that work in primary and secondary education. Pre-post changes will be assessed. Experimental group will use the app until they finish it (within a set period of 10 days), whereas control group will do nothing for 10 days. Primarily, it is expected that after the use of the app, participants will show an improvement in OCD-related literacy, stigmatizing attitudes, desired social distance and their comfort, confidence and perceived ability in teaching and handling students with OCD. Secondarily, the investigators hypothesize that experimental group might show a reduction in obsessive-compulsive symptoms.

The 2 groups in the trial

  • Use of esTOCmaTreatment being tested

    Experimental group will use esTOCma until they finish it (within a preestablished 10-days period).

  • Control groupNo study treatment, for comparison

    Control group will do nothing for 10 days.

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
A RCT of a Mobile App (esTOCma) to Improve Mental Health Literacy, Stigmatizing Attitudes Related to OCD, and Confidence in Dealing With Students With OCD in Teachers
Record updated
30 December 2025